Search research articles
Contact Us
Filters
Showing results (1-10 of 121) with videos related to
Page
of 13
Sort By:
Clinical and Experimental Pharmacology & Physiology
|
December 2, 2017
Obstacles and challenges for tissue engineering and regenerative medicine: Australian nuances
Miranda D Grounds
Bioarchitecture
|
August 8, 2014
Therapies for sarcopenia and regeneration of old skeletal muscles: more a case of old tissue architecture than old stem cells
Miranda D Grounds
The International Journal of Biochemistry & Cell Biology
|
September 23, 2014
The need to more precisely define aspects of skeletal muscle regeneration
Miranda D Grounds
Biogerontology
|
May 17, 2002
Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling
Miranda D Grounds
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
June 10, 2010
Comments on Point:Counterpoint: IGF is/is not the major physiological regulator of muscle mass. IGF-1 is a major regulator of muscle mass during growth but not for adult myofiber hypertrophy
Thea Shavlakadze, Miranda D Grounds
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
April 19, 2011
Growing muscle has different sarcolemmal properties from adult muscle: a proposal with scientific and clinical implications: reasons to reassess skeletal muscle molecular dynamics, cellular responses and suitability of experimental models of muscle disorders
Miranda D Grounds, Thea Shavlakadze
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 1, 2004
Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis
Miranda D Grounds, Jo Torrisi
The International Journal of Biochemistry & Cell Biology
|
October 15, 2014
Regenerative medicine: the challenge of translation. Editorial
Nadia Rosenthal, Miranda D Grounds
Journal of Cell Science
|
September 16, 2003
Irradiation of dystrophic host tissue prior to myoblast transfer therapy enhances initial (but not long-term) survival of donor myoblasts
Stuart I Hodgetts, Miranda D Grounds
Journal of Neuromuscular Diseases
|
November 6, 2023
Considering the Promise of Vamorolone for Treating Duchenne Muscular Dystrophy
Miranda D Grounds, Erin M Lloyd
Page
of 13
Search research articles
Search
Showing results (1-10 of 121) with videos related to
Sort By:
Page
of 13
Clinical and Experimental Pharmacology & Physiology
|
December 2, 2017
Obstacles and challenges for tissue engineering and regenerative medicine: Australian nuances
Miranda D Grounds
Bioarchitecture
|
August 8, 2014
Therapies for sarcopenia and regeneration of old skeletal muscles: more a case of old tissue architecture than old stem cells
Miranda D Grounds
The International Journal of Biochemistry & Cell Biology
|
September 23, 2014
The need to more precisely define aspects of skeletal muscle regeneration
Miranda D Grounds
Biogerontology
|
May 17, 2002
Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling
Miranda D Grounds
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
June 10, 2010
Comments on Point:Counterpoint: IGF is/is not the major physiological regulator of muscle mass. IGF-1 is a major regulator of muscle mass during growth but not for adult myofiber hypertrophy
Thea Shavlakadze, Miranda D Grounds
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
April 19, 2011
Growing muscle has different sarcolemmal properties from adult muscle: a proposal with scientific and clinical implications: reasons to reassess skeletal muscle molecular dynamics, cellular responses and suitability of experimental models of muscle disorders
Miranda D Grounds, Thea Shavlakadze
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 1, 2004
Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis
Miranda D Grounds, Jo Torrisi
The International Journal of Biochemistry & Cell Biology
|
October 15, 2014
Regenerative medicine: the challenge of translation. Editorial
Nadia Rosenthal, Miranda D Grounds
Journal of Cell Science
|
September 16, 2003
Irradiation of dystrophic host tissue prior to myoblast transfer therapy enhances initial (but not long-term) survival of donor myoblasts
Stuart I Hodgetts, Miranda D Grounds
Journal of Neuromuscular Diseases
|
November 6, 2023
Considering the Promise of Vamorolone for Treating Duchenne Muscular Dystrophy
Miranda D Grounds, Erin M Lloyd
Page
of 13